BRIDGE HCV: Building Bridges to Reach People Who Inject Drugs with the Goal to Eliminate HCV
| Overview / Abstract: |
The goals of this activity are to prepare community-based HCV treaters to provide effective therapy for HCV-positive people who inject drugs (PWID), to increase HCV testing and treatment of PWIDs through proactive risk identification and referral by addiction-services centers, and to educate HCV-care specialists and addiction-services personnel regarding harm-reduction principles and the prevention of HCV reinfection. |
|
Expiration |
Feb 08, 2019 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
0.75 |
|
Accreditation |
ACCME, ACPE, ANCC, CE |
|
Presenters / Authors / Faculty |
Stacey Trooskin, MD, PhD |
|
Sponsors / Supporters / Grant Providers |
This CME/CE activity is supported by educational grants from Gilead Sciences, Inc. and Merck & Co., Inc and jointly provided by Purdue University College of Pharmacy and Integritas Communications. |
|
Keywords / Search Terms |
Integritas Communications Integritas Communications, HCV, Hepatitis C, PWID, positive people who inject drugs, HCV reinfection, CME, CE, Continuing Medical Education, Continuing Education, Free CME, Free CE, video, webcast, Trooskin Free CE CME |
|